TP53 and non-small cell lung carcinoma: Eighteen CRC tumor cultures were from NSCLC specimens with a total of 22 known oncogene mutations such as KRAS, EGFR, PTEN, TP53 or ALK rearrangements demonstrated in the primary tumor specimens at diagnosis (Supplementary Table S1).